The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

Detalles Bibliográficos
Autores principales: Barnett, G, Flashman, E, Kelly, D, Schofield, C, Gershlick, A
Formato: Conference item
Publicado: 2013

Ejemplares similares